Glanbia acquired SlimFast, adding to its performance nutrition portfolio
Glanbia plc has agreed to acquire SlimFast and other brands from Kainos Capital (Dallas, TX), the parent company of KSF Holdings LLP and SlimFast sister company HNS Intermediate Corporation, for $350 million.
Photo © iStockphoto.com/skynesher
Glanbia plc has agreed to acquire SlimFast and other brands from Kainos Capital (Dallas, TX), the parent company of KSF Holdings LLP and SlimFast sister company HNS Intermediate Corporation, for $350 million. Kainos originally acquired SlimFast from Unilever in 2017. With products distributed primarily in the food, drug, mass market, and club channels in both the United States and United Kingdom, in 2017 the company delivered $212 million in net sales, adjusted earnings before interest, tax, depreciation and amortization of $24 million, and after non-recurring supply chain costs, a net loss of $12 million. SlimFast’s gross assets at the end of the 2017 financial year were $136 million.
“I am pleased to announce that we have agreed to acquire SlimFast, a leading consumer brand in the $8 billion weight-management nutrition market, an adjacency to the Glanbia Performance Nutrition brand portfolio. SlimFast is an established and enduring brand and, along with nutritional supplements brands Healthy Delights and Nu-Therapy, complements our existing portfolio targeting lifestyle consumers,” said Siobhán Talbot, group managing director of Glanbia, in a press release. “It plays to global consumer trends focused on convenient formats and snacking. The transaction is in line with our strategic ambition to extend the reach of our Glanbia Performance Nutrition portfolio to related consumer needs.”
Reflecting on the growth of SlimFast under the ownership of Kainos, Kainos managing partner Andrew Rosen said in a press release, “Our acquisition of SlimFast came with no employees or systems. Behind the leadership of CEO Chris Tisi, who we partnered with when we invested in his company HNS in 2014, we quickly built a 60-plus person team in the U.S. and the UK. This team, combined with our own internal resources, did a great job revitalizing what was an orphan brand within a large multinational company. SlimFast is positioned to continue its great success as a part of Glanbia.”
The transaction is expected to be completed by the end of 2018.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
